Filing Flows

Filing Flows › NRX Pharmaceuticals (NRXP) › Who owns the stock

Who owns NRX Pharmaceuticals (NRXP) stock

44 funds reported NRX Pharmaceuticals (NRXP) shares in their latest 13F filings, worth $49.1M in all. The largest holder is B Group ($16.7M). Last quarter 33 funds added to their stakes and 10 cut them.

Largest holders of NRXP (13F)Largest holders of NRXP (13F)B Group$16.7MVanguard Capital Management LLC$6.6MAmeriprise Financial$3.8MBalyasny Asset Management L.P.$3.7MCitadel Advisors LLC$2.8MAdvisorShares Investments LLC$2.7MVanguard Group$2.0MCommonwealth Equity Services, LLC$1.9MUBS Group AG$1.7MGeode Capital Management, LLC$1.3M

Largest holders (13F)

FundSharesValueChangeQuarter
B Group4,091,767$16.7Mincrease2026-06-30
Vanguard Capital Management LLC1,618,159$6.6Mincrease2026-06-30
Ameriprise Financial928,728$3.8Mnew2026-06-30
Balyasny Asset Management L.P.893,864$3.7Mnew2026-06-30
Citadel Advisors LLC680,043$2.8Mnew2026-06-30
AdvisorShares Investments LLC659,018$2.7Mincrease2026-06-30
Vanguard Group729,842$2.0Mincrease2025-12-31
Commonwealth Equity Services, LLC454,418$1.9Mincrease2026-06-30
UBS Group AG423,115$1.7Mincrease2026-06-30
Geode Capital Management, LLC314,659$1.3Mincrease2026-06-30
BlackRock220,460$902Kincrease2026-06-30
Marshall Wace, LLP194,580$796Knew2026-06-30
Vanguard Fiduciary Trust182,718$747Kincrease2026-06-30
Jane Street Group, LLC119,018$487Kincrease2026-06-30
Bleakley Financial Group, LLC117,216$479Kincrease2026-06-30

NRX Pharmaceuticals' latest quarter

NRX Pharmaceuticals, Q2 2026: revenue $1.1M, operating margin -590.8%, net loss $16.5M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most NRXP stock?

By the latest 13F filings: B Group ($16.7M); Vanguard Capital Management LLC ($6.6M); Ameriprise Financial ($3.8M); Balyasny Asset Management L.P. ($3.7M); Citadel Advisors LLC ($2.8M).

What is the short interest in NRXP?

9,949,938 shares were sold short at the 2026-10-15 settlement, 1.59% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.